Association of Atrial Fibrillation Burden and Mortality Among Patients With Cardiac Implantable Electronic Devices
Circulation · 2024
DOI: 10.1161/circulationaha.124.069757 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, 2024. Verfasst von Graham Peigh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, IL (G.P., K.T., T.N., R.S.P.). Hauptthemen laut MEDLINE: Atrial Fibrillation, Defibrillators, Implantable. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Current estimates of atrial fibrillation (AF)–associated mortality rely on claims- or clinical-derived diagnoses of AF, limit AF to a binary entity, or are confounded by comorbidities. The objective of the present study is to assess the association between device-recognized AF and mortality among patients with cardiac implantable electronic devices capable of sensitive and continuous atrial arrhythmia detection. Secondary outcomes include relative mortality among cohorts with no AF, paroxysmal AF, persistent AF, and permanent AF. METHODS: Using the deidentified Optum Clinformatics US claims database (2015 to 2020) linked to the Medtronic CareLink database, we identified individuals with a cardiac implantable electronic device who transmitted data ≥6 months after implantation. AF burden was assessed during the first 6 months after implantation (baseline period). Subsequent mortality, assessed from claims data, was compared between patients with and without AF, with adjustment for age, geographic region, insurance type, Charlson Comorbidity Index, and implantation year. RESULTS: Of 21 391 patients (age, 72.9±10.9 years; 56.3% male) analyzed, 7798 (36.5%) had device-recognized AF. During a mean of 22.4±12.9 months (median, 20.1 [12.8–29.7] months) of follow-up, the overall incidence of mortality was 13.5%. Patients with AF had higher adjusted all-cause mortality than patients without AF (hazard ratio, 1.29 [95% CI, 1.20–1.39]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, IL (G.P., K.T., T.N., R.S.P.).
- Medtronic Inc, Minneapolis, MN (J.Z., S.C.R., A.I.R., C.L., D.S.).
- Brown University School of Public Health, Providence, RI (A.I.R.).
ORCID-Profile: Graham Peigh, Jiani Zhou, Sarah C Rosemas, Tanvi Nayak, Dana Soderlund
Förderung
- NHLBI NIH HHS
Zitieren
APA
Peigh, G., Zhou, J., Rosemas, S. C., Roberts, A. I., Longacre, C., Trinh, K., Nayak, T., Soderlund, D., & Passman, R. S. (2024). Association of Atrial Fibrillation Burden and Mortality Among Patients With Cardiac Implantable Electronic Devices. Circulation. https://doi.org/10.1161/circulationaha.124.069757
Vancouver
Peigh G, Zhou J, Rosemas SC, Roberts AI, Longacre C, Trinh K, et al. Association of Atrial Fibrillation Burden and Mortality Among Patients With Cardiac Implantable Electronic Devices. Circulation. 2024. doi:10.1161/circulationaha.124.069757
BibTeX
@article{Peigh2024,
author = {Peigh, Graham and Zhou, Jiani and Rosemas, Sarah C and Roberts, Anthony I and Longacre, Colleen and Trinh, Katherine and Nayak, Tanvi and Soderlund, Dana and Passman, Rod S},
title = {Association of Atrial Fibrillation Burden and Mortality Among Patients With Cardiac Implantable Electronic Devices},
journal = {Circulation},
year = {2024},
doi = {10.1161/circulationaha.124.069757}
}
EUVIMED